{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:39:46Z","timestamp":1786995586842,"version":"build-2736575974"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pharmthera.2024.108751","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:37:16Z","timestamp":1731112636000},"page":"108751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The potential therapeutic strategy in combating neurodegenerative diseases: Focusing on natural products"],"prefix":"10.1016","volume":"264","author":[{"given":"Li","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xiao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Le","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Song","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Long","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Run","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pharmthera.2024.108751_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14253","article-title":"Ginkgo biloba protects striatal neurodegeneration and gut phagoinflammatory damage in rotenone-induced mice model of Parkinson\u2019s disease: Role of executioner caspase-3\/Nrf2\/AREsignaling","volume":"46","author":"Adebayo","year":"2022","journal-title":"Journal of Food Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0010","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pharep.2015.03.002","article-title":"Berberine and neurodegeneration: A review of literature","volume":"67","author":"Ahmed","year":"2015","journal-title":"Pharmacological Reports"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0015","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3390\/biomedicines10112866","article-title":"Beta-boswellic acid reverses 3-nitropropionic acid-induced molecular, mitochondrial, and histopathological defects in experimental rat model of Huntington\u2019s disease","volume":"10","author":"Albekairi","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/19390211.2019.1710646","article-title":"Fisetin improved rotenone-induced behavioral deficits, oxidative changes, and mitochondrial dysfunctions in rat model of Parkinson\u2019s disease","volume":"18","author":"Alikatte","year":"2020","journal-title":"Journal of Dietary Supplements"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122257","article-title":"Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview","volume":"334","author":"Alshial","year":"2023","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/pharmaceutics15010212","article-title":"Therapeutic potential of natural compounds in neurodegenerative diseases: Insights from clinical trials","volume":"15","author":"Andrade","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12031-021-01922-7","article-title":"Emerging novel approaches for the enhanced delivery of natural products for the management of neurodegenerative diseases","volume":"72","author":"Bandiwadekar","year":"2022","journal-title":"Journal of Molecular Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0040","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/acs.jafc.1c07241","article-title":"Tangeretin inhibits BACE1 activity and attenuates cognitive impairments in AD model mice","volume":"70","author":"Bao","year":"2022","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0045","first-page":"37","article-title":"Mitochondrial dysfunction and multiple sclerosis","volume":"8","author":"Barcelos","year":"2019","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: Findings from the ocrelizumab randomised, double-blind phase 3 clinical trials","volume":"93","author":"Bar-Or","year":"2023","journal-title":"Ebiomedicine"},{"issue":"18","key":"10.1016\/j.pharmthera.2024.108751_bb0055","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.3390\/ijms22189753","article-title":"Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection","volume":"22","author":"Bellingacci","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"23","key":"10.1016\/j.pharmthera.2024.108751_bb0060","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.3390\/ijms242316833","article-title":"Mitochondrial dyshomeostasis as an early hallmark and a therapeutic target in amyotrophic lateral sclerosis","volume":"24","author":"Belosludtseva","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-151020","article-title":"Clearing amyloid-\u03b2 through PPAR\u03b3\/ApoE activation by genistein is a treatment of experimental Alzheimer\u2019s disease","volume":"51","author":"Bonet-Costa","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0070","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s10072-021-05527-1","article-title":"Deep brain stimulation in Huntington\u2019s disease: A literature review","volume":"42","author":"Bonomo","year":"2021","journal-title":"Neurological Sciences"},{"issue":"7355","key":"10.1016\/j.pharmthera.2024.108751_bb0075","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/475S1a","article-title":"Alzheimer's disease","volume":"475","author":"Brody","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/antiox12020378","article-title":"Current techniques of water solubility improvement for antioxidant compounds and their correlation with its activity: Molecular pharmaceutics","volume":"12","author":"Budiman","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104421","article-title":"Epigallocatechin-3 gallate regulates macrophage subtypes and immunometabolism to ameliorate experimental autoimmune encephalomyelitis","volume":"368","author":"Cai","year":"2021","journal-title":"Cellular Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bib859","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07594.x","article-title":"Resveratrol mitigates lipopolysaccharide\u2010 and A\u03b2\u2010mediated microglial inflammation by inhibiting the TLR4\/NF\u2010\u03baB\/STAT signaling cascade","volume":"120","author":"Capiralla","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuron.2021.10.033","article-title":"Developmental defects in Huntington's disease show that axonal growth and microtubule reorganization require NUMA1","volume":"110","author":"Capizzi","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1073858420972662","article-title":"Synaptic dysfunction in Huntington\u2019s disease: Lessons from genetic animal models","volume":"28","author":"Cepeda","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104928","article-title":"Deep brain stimulation in multiple sclerosis-associated tremor. A large, retrospective, longitudinal open label study, with long-term follow-up","volume":"79","author":"Chagot","year":"2023","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cns.12189","article-title":"Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease","volume":"20","author":"Chakraborty","year":"2013","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108751_bb0115","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/biom13081196","article-title":"Polyphenols, autophagy and neurodegenerative diseases: A review","volume":"13","author":"Chandrasekaran","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12929-016-0290-z","article-title":"Therapeutic effect of berberine on TDP-43 related pathogenesis in FTLD and ALS","volume":"23","author":"Chang","year":"2016","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112866","article-title":"The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity","volume":"149","author":"Chen","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"17","key":"10.1016\/j.pharmthera.2024.108751_bb0130","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1073\/pnas.1702237114","article-title":"Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington\u2019s disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108751_bb0135","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/nu14071417","article-title":"The neuroprotection of verbascoside in Alzheimer\u2019s disease mediated through mitigation of neuroinflammation via blocking NF-\u03baB-p65 signaling","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147904","article-title":"The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics","volume":"1786","author":"Chen","year":"2022","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109670","article-title":"Berberine mitigates cognitive decline in an Alzheimer\u2019s disease mouse model by targeting both tau hyperphosphorylation and autophagic clearance","volume":"121","author":"Chen","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","article-title":"Synaptic dysfunction in Alzheimer\u2019s disease: Mechanisms and therapeutic strategies","volume":"195","author":"Chen","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mrfmmm.2014.11.010","article-title":"DNA damage in neurodegenerative diseases","volume":"776","author":"Copped\u00e8","year":"2015","journal-title":"Mutation Research"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155101","article-title":"Natural products for the treatment of neurodegenerative diseases","volume":"121","author":"Cui","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.fct.2018.08.028","article-title":"Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-\u03b3, Bax\/Bcl-2, and caspase-3","volume":"121","author":"Cui","year":"2018","journal-title":"Food and Chemical Toxicology"},{"issue":"7363","key":"10.1016\/j.pharmthera.2024.108751_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0180","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s13311-020-00900-y","article-title":"Complementary therapies in Parkinson disease: A review of acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis","volume":"17","author":"Deuel","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"19","key":"10.1016\/j.pharmthera.2024.108751_bb0185","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","article-title":"Inhibition of protein misfolding and aggregation by natural phenolic compounds","volume":"75","author":"Dhouafli","year":"2018","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.105925","article-title":"Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson\u2019s disease","volume":"26","author":"Dick","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-021-02194-z","article-title":"Phloretin suppresses neuroinflammation by autophagy-mediated Nrf2 activation in macrophages","volume":"18","author":"Dierckx","year":"2021","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: Molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Research Reviews"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108751_bb0205","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12974-017-1036-x","article-title":"Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia","volume":"14","author":"Fan","year":"2017","journal-title":"Journal of Neuroinflammation"},{"issue":"10360","key":"10.1016\/j.pharmthera.2024.108751_bb0215","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109118","article-title":"Genistein attenuates memory impairment in Alzheimer's disease via ERS-mediated apoptotic pathway in vivo and in vitro","volume":"109","author":"Gao","year":"2022","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106227","article-title":"Daphnetin ameliorates A\u03b2 pathogenesis via STAT3\/GFAP signaling in an APP\/PS1 double-transgenic mouse model of Alzheimer\u2019s disease","volume":"180","author":"Gao","year":"2022","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113721","article-title":"New insights into the role of berberine against 3-nitropropionic acid-induced striatal neurotoxicity: Possible role of BDNF\u2013TrkB\u2013PI3K\/Akt and NF-\u03baB signaling","volume":"175","author":"Gendy","year":"2023","journal-title":"Food and Chemical Toxicology"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bib872","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22410","article-title":"Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double-blind, randomized, and placebo-controlled trial","volume":"33","author":"Ghiasian","year":"2019","journal-title":"Journal of Biochemical And Molecular Toxicology"},{"key":"10.1016\/j.pharmthera.2024.108751_bib874","doi-asserted-by":"crossref","unstructured":"Gomes, B.A.Q., Silva, J.P.B., Romeiro, C.F.R., dos Santos, S.M., Rodrigues, C.A., Gon\u00e7alves, P.R., et al. (2018). Neuroprotective mechanisms of resveratrol in Alzheimer's disease: Role of SIRT1. Oxidative Medicine and Cellular Longevity, 2018, 8152373.","DOI":"10.1155\/2018\/8152373"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bib876","first-page":"22","article-title":"Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): A pilot clinical trial","volume":"9","author":"Gonzales","year":"2022","journal-title":"The journal of prevention of Alzheimer\u2019s disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jnr.24592","article-title":"DNA damage and repair in Parkinson\u2019s disease: Recent advances and new opportunities","volume":"99","author":"Gonzalez-Hunt","year":"2021","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bib865","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-020-01009-8","article-title":"Involvement of \u03b17nAChR in the protectiveeffects of genistein against \u03b2-amyloid-induced oxidative stress in neurons via a PI3K\/Akt\/Nrf2 pathway-related mechanism","volume":"41","author":"Guo","year":"2020","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175046","article-title":"Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK","volume":"927","author":"Habib","year":"2022","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0245","article-title":"Maintenance of mitochondrial homeostasis for Alzheimer\u2019s disease: Strategies and challenges","volume":"63","author":"Han","year":"2023","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0250","article-title":"Camptothecin regulates microglia polarization and exerts neuroprotective effects via activating AKT\/Nrf2\/HO-1 and inhibiting NF-\u03baB pathways in vivo and in vitro","volume":"12","author":"He","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102848","article-title":"Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor \u03b3-dependent mechanism in Alzheimer\u2019s disease","volume":"66","author":"He","year":"2023","journal-title":"Redox Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0260","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.brs.2023.03.003","article-title":"Continuous vagus nerve stimulation exerts beneficial effects on rats with experimentally induced Parkinson's disease: Evidence suggesting involvement of a vagal afferent pathway","volume":"16","author":"Hosomoto","year":"2023","journal-title":"Brain Stimulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bb0265","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/ptr.6193","article-title":"Ginsenoside Rg3 and Rh2 protect trimethyltin-induced neurotoxicity via prevention on neuronal apoptosis and neuroinflammation","volume":"32","author":"Hou","year":"2018","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0270","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/DDDT.S156920","article-title":"Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K\/Akt signaling pathway","volume":"12","author":"Hu","year":"2018","journal-title":"Drug Design Development and Therapy"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0275","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3389\/fimmu.2018.02527","article-title":"Polydatin prevents lipopolysaccharide (LPS)-induced Parkinson\u2019s disease via regulation of the AKT\/GSK3\u03b2-Nrf2\/NF-\u03baB signaling axis","volume":"9","author":"Huang","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110820","article-title":"Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease","volume":"387","author":"Huang","year":"2024","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110653","article-title":"Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K\/Akt signaling pathway","volume":"124","author":"Huang","year":"2019","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.618787","article-title":"Berberine protects against NLRP3 inflammasome via ameliorating autophagic impairment in MPTP-induced Parkinson\u2019s disease model","volume":"11","author":"Huang","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105851","article-title":"Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease","volume":"173","author":"Imbriani","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0300","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","article-title":"Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-\u03baB pathways","volume":"53","author":"Jang","year":"2015","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0305","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbi.2019.03.001","article-title":"Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington\u2019s disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors","volume":"80","author":"Jang","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108751_bb0310","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3390\/biomedicines10081895","article-title":"Therapeutic strategies in Huntington\u2019s disease: From genetic defect to gene therapy","volume":"10","author":"Jurcau","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0315","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pneurobio.2012.08.004","article-title":"Therapeutic approaches to preventing cell death in Huntington disease","volume":"99","author":"Kaplan","year":"2012","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105211","article-title":"Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2\/HO-1 and TLR4\/NF-\u03baB signaling","volume":"151","author":"Khan","year":"2021","journal-title":"Neurochemistry International"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12031-020-01637-1","article-title":"Sinomenine alleviates murine experimental autoimmune encephalomyelitis model of multiple sclerosis through inhibiting NLRP3 inflammasome","volume":"71","author":"Kiasalari","year":"2021","journal-title":"Journal of Molecular Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: Consequences for remyelination and disease progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nature Reviews Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0340","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2005.10.056","article-title":"The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice","volume":"395","author":"Koh","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.786420","article-title":"DNA damage, defective DNA repair, and neurodegeneration in amyotrophic lateral sclerosis","volume":"14","author":"Konopka","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0350","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41401-021-00702-8","article-title":"Luteolin alleviates cognitive impairment in Alzheimer\u2019s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation","volume":"43","author":"Kou","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108751_bb0355","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3390\/nu12061824","article-title":"Protocatechuic acid extends survival, improves motor function, diminishes gliosis, and sustains neuromuscular junctions in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Koza","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108751_bb0360","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jnr.24824","article-title":"Synaptic dysfunction in amyotrophic lateral sclerosis\/frontotemporal dementia: Therapeutic strategies and novel biomarkers","volume":"99","author":"Krishnamurthy","year":"2021","journal-title":"Journal of Neuroscience Research"},{"issue":"22","key":"10.1016\/j.pharmthera.2024.108751_bb0365","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.3390\/ijms20225553","article-title":"Carotenoids as novel therapeutic molecules against neurodegenerative disorders: Chemistry and molecular docking analysis","volume":"20","author":"Lakey-Beitia","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"19","key":"10.1016\/j.pharmthera.2024.108751_bb0370","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.3390\/ijms221910285","article-title":"RNA deregulation in amyotrophic lateral sclerosis: The noncoding perspective","volume":"22","author":"Laneve","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108751_bb0375","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00018-023-04797-6","article-title":"Neurofilament accumulations in amyotrophic lateral sclerosis patients\u2019 motor neurons impair axonal initial segment integrity","volume":"80","author":"Lefebvre-Omar","year":"2023","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"13","key":"10.1016\/j.pharmthera.2024.108751_bib868","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.3390\/ijms22137225","article-title":"EVOO polyphenols relieve synergistically autophagy dysregulation in a cellular model of Alzheimer\u2019s disease","volume":"22","author":"Leri","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0380","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbi.2019.08.194","article-title":"Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer\u2019s disease","volume":"82","author":"Li","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnagi.2020.00155","article-title":"Prevention of early Alzheimer\u2019s disease by Erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study","volume":"12","author":"Li","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0390","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2019.10.408","article-title":"Acteoside ameliorates experimental autoimmune encephalomyelitis through inhibiting peroxynitrite-mediated mitophagy activation","volume":"146","author":"Li","year":"2020","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0395","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3389\/fimmu.2018.01807","article-title":"Carnosol modulates Th17 cell differentiation and microglial switch in experimental autoimmune encephalomyelitis","volume":"9","author":"Li","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108751_bb0400","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/cns.12555","article-title":"7,8-dihydroxyflavone ameliorates motor deficits via suppressing \u03b1-synuclein expression and oxidative stress in the MPTP-induced mouse model of Parkinson\u2019s disease","volume":"22","author":"Li","year":"2016","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0405","doi-asserted-by":"crossref","first-page":"7769355","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin protects against MPP+\/MPTP-induced dopaminergic neuron death in Parkinson\u2019s disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0410","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","article-title":"Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models","volume":"14","author":"Liu","year":"2018","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13578-023-01129-w","article-title":"Astaxanthin attenuates cognitive deficits in Alzheimer\u2019s disease models by reducing oxidative stress via the SIRT1\/PGC-1\u03b1 signaling pathway","volume":"13","author":"Liu","year":"2023","journal-title":"Cell & Bioscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-201614","article-title":"Neoline improves memory impairment and reduces amyloid-\u03b2 level and tau phosphorylation through AMPK activation in the mouse Alzheimer\u2019s disease model","volume":"81","author":"Liu","year":"2021","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0425","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2015.01.011","article-title":"Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"46","author":"Liu","year":"2015","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113017","article-title":"Kaempferol prevents the activation of complement C3 protein and the generation of reactive A1 astrocytes that mediate rat brain degeneration induced by 3-nitropropionic acid","volume":"164","author":"Lopez-Sanchez","year":"2022","journal-title":"Food and Chemical Toxicology"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0435","first-page":"565","article-title":"Astaxanthin reduces demyelination and oligodendrocytes death in A rat model of multiple sclerosis","volume":"22","author":"Lotfi","year":"2021","journal-title":"Cell Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108751_bb0440","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41423-022-00883-0","article-title":"Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis","volume":"19","author":"Luoqian","year":"2022","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134599","article-title":"Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis","volume":"715","author":"Ma","year":"2020","journal-title":"Neuroscience Letters"},{"issue":"Pt A","key":"10.1016\/j.pharmthera.2024.108751_bb0450","article-title":"Baicalein inhibits the polarization of microglia\/macrophages to the M1 phenotype by targeting STAT1 in EAE mice","volume":"113","author":"Ma","year":"2022","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0455","doi-asserted-by":"crossref","first-page":"1154180","DOI":"10.3389\/fnins.2023.1154180","article-title":"Deep brain stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis","volume":"17","author":"Majdi","year":"2023","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0460","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","article-title":"Resveratrol improves Motoneuron function and extends survival in SOD1-G93A ALS mice","volume":"11","author":"Mancuso","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bib871","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028486","article-title":"Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)","volume":"9","author":"Mandrioli","year":"2019","journal-title":"Bmj Open"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102575","article-title":"How neurons die in Alzheimer\u2019s disease: Implications for neuroinflammation","volume":"75","author":"Mangalmurti","year":"2022","journal-title":"Current Opinion in Neurobiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0470","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-018-1933-9","article-title":"Inflammation in ALS\/FTD pathogenesis","volume":"137","author":"McCauley","year":"2019","journal-title":"Acta Neuropathologica"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bb0475","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington\u2019s disease: An updated systematic review and meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147639","article-title":"Defining (and blocking) neuronal death in Parkinson's disease: Does it matter what we call it?","volume":"1771","author":"Memou","year":"2021","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bib870","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-134722","article-title":"Ginkgo biloba efficacy in the treatment of drug-induced Parkinsonism: A randomized clinical trial","volume":"22","author":"Mohebbi","year":"2023","journal-title":"Iranian Journal of Pharmaceutical Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bib856","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1038\/s41598-023-32515-6","article-title":"A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress","volume":"13","author":"Morat\u00f3","year":"2023","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108751_bb0485","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","article-title":"Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington\u2019s disease models","volume":"54","author":"Naia","year":"2016","journal-title":"Molecular Neurobiology"},{"issue":"37","key":"10.1016\/j.pharmthera.2024.108751_bb0490","doi-asserted-by":"crossref","first-page":"10243","DOI":"10.1039\/D0SC02046J","article-title":"Multiple reactivities of flavonoids towards pathological elements in Alzheimer\u2019s disease: Structure-activity relationship","volume":"11","author":"Nam","year":"2020","journal-title":"Chemical Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0495","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jgr.2020.04.002","article-title":"Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor","volume":"45","author":"Nam","year":"2021","journal-title":"Journal of Ginseng Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bib857","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-220953","article-title":"Effects of melissa officinalis extract containing rosmarinic acid on cognition in older adults without dementia: A randomized controlled trial","volume":"91","author":"Noguchi-Shinohara","year":"2023","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155065","article-title":"Ginsenoside-re inhibits experimental autoimmune encephalomyelitis as a mouse model of multiple sclerosis by downregulating TLR4\/MyD88\/NF-kappaB signaling pathways","volume":"122","author":"Oh","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0505","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.plaphy.2019.09.039","article-title":"What is responsible for antioxidant properties of polyphenolic compounds from plants?","volume":"144","author":"Olszowy","year":"2019","journal-title":"Plant Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0510","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","article-title":"Ubiquitin-proteasome system involvement in Huntington\u2019s disease","volume":"7","author":"Ortega","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0515","article-title":"FOXO3 directly regulates an autophagy network to functionally regulate proteostasis in adult neural stem cells","volume":"15","author":"Paik","year":"2019","journal-title":"PLoS Genetics"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108751_bb0520","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson's disease","volume":"145","author":"Pan","year":"2022","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.pharmthera.2024.108751_bb0525","first-page":"1068","article-title":"Dynamic microtubules in Alzheimer\u2019s disease: Association with dendritic spine pathology","volume":"83","author":"Pchitskaya","year":"2018","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0530","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00018-016-2351-6","article-title":"Back to the tubule: Microtubule dynamics in Parkinson\u2019s disease","volume":"74","author":"Pellegrini","year":"2017","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0535","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/15548627.2023.2286116","article-title":"Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation","volume":"20","author":"Pierzynowska","year":"2023","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0540","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12031-021-01951-2","article-title":"Paeonol ameliorates cuprizone-induced hippocampal demyelination and cognitive deficits through inhibition of oxidative and inflammatory events","volume":"72","author":"Pourmohammadi","year":"2022","journal-title":"Journal of Molecular Neuroscience"},{"issue":"18","key":"10.1016\/j.pharmthera.2024.108751_bb0545","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1021\/acs.jafc.9b00133","article-title":"Nobiletin protects against systemic inflammation-stimulated memory impairment via MAPK and NF-\u03baB signaling pathways","volume":"67","author":"Qi","year":"2019","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0550","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","article-title":"Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration","volume":"16","author":"Querfurth","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"17","key":"10.1016\/j.pharmthera.2024.108751_bb0555","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3390\/molecules26175327","article-title":"Therapeutic potential of natural products in treating neurodegenerative disorders and their future prospects and challenges","volume":"26","author":"Rahman","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biopha.2018.11.043","article-title":"Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by A\u03b2 peptides in animal model of Alzheimer\u2019s disease","volume":"110","author":"Rahman","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bib864","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1017\/S0007114516001203","article-title":"Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults","volume":"115","author":"Rainey-Smith","year":"2016","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153627","article-title":"Tetrandrine ameliorated Alzheimer's disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse","volume":"90","author":"Ren","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0570","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodriguez Murua","year":"2022","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10.1016\/j.pharmthera.2024.108751_bib858","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2018.03.028","article-title":"Rosmarinic acid attenuates \u03b2-amyloid-induced oxidative stress via Akt\/GSK-3\u03b2\/Fyn-mediated Nrf2 activation in PC12 cells","volume":"120","author":"Rong","year":"2018","journal-title":"Free Radical Biology and Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108751_bb0575","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/acn3.51419","article-title":"Evaluation of peripherin in biofluids of patients with motor neuron diseases","volume":"8","author":"Sabbatini","year":"2021","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107900","article-title":"Neuroprotective effect of crocin against rotenone-induced Parkinson\u2019s disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","volume":"164","author":"Salama","year":"2020","journal-title":"Neuropharmacology"},{"issue":"28","key":"10.1016\/j.pharmthera.2024.108751_bb0585","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury","volume":"35","author":"Santos-Nogueira","year":"2015","journal-title":"Journal of Neuroscience"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0590","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(23)00247-8","article-title":"Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer's disease","volume":"22","author":"Schlepckow","year":"2023","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0595","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/cells12111478","article-title":"Deep brain stimulation beyond the clinic: Navigating the future of Parkinson\u2019s and Alzheimer\u2019s disease therapy","volume":"12","author":"Senevirathne","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2023.102363","article-title":"Curcumin alleviates Alzheimer\u2019s disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway","volume":"134","author":"Shao","year":"2023","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.794458","article-title":"Baicalein ameliorates A\u03b2-induced memory deficits and neuronal atrophy via inhibition of PDE2 and PDE4","volume":"12","author":"Shi","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0610","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/s41598-023-29287-4","article-title":"Oleuropein confers neuroprotection against rotenone-induced model of Parkinson\u2019s disease via BDNF\/CREB\/Akt pathway","volume":"13","author":"Singh","year":"2023","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.167992","article-title":"Common mechanisms underlying \u03b1-synuclein-induced mitochondrial dysfunction in Parkinson\u2019s disease","volume":"435","author":"Sohrabi","year":"2023","journal-title":"Journal of Molecular Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0620","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.18632\/oncotarget.27963","article-title":"Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network","volume":"12","author":"Sonawane","year":"2021","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108751_bb0625","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0630","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","article-title":"Huntington\u2019s disease: Diagnosis and management","volume":"22","author":"Stoker","year":"2022","journal-title":"Practical Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0635","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1039\/C9FO02131K","article-title":"Ellagic acid rescues motor and cognitive deficits in the R6\/2 mouse model of Huntington's disease by lowering mutant huntingtin protein","volume":"11","author":"Sun","year":"2020","journal-title":"Food & Function"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0640","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40265-020-01268-1","article-title":"Sodium oligomannate: First approval","volume":"80","author":"Syed","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112968","article-title":"Isoorientin, a GSK-3\u03b2 inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP\/PS1 model mice","volume":"398","author":"Tan","year":"2021","journal-title":"Behavioural Brain Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0650","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nature Reviews Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108751_bb0655","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00210-023-02424-6","article-title":"Protective effect of crocin on cuprizone-induced model of multiple sclerosis in mice","volume":"396","author":"Tashakori","year":"2023","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0660","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.766","article-title":"Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells","volume":"11","author":"Tavaf","year":"2023","journal-title":"Immunity Inflammation and Disease"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0665","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopha.2016.09.070","article-title":"Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats","volume":"84","author":"Thangarajan","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bib867","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12929-016-0266-z","article-title":"Erinacine a-enriched hericium erinaceus mycelium ameliorates Alzheimer\u2019s disease-related pathologies in APPswe\/PS1dE9 transgenic mice","volume":"23","author":"Tsai-Teng","year":"2016","journal-title":"Journal of Biomedical Science"},{"issue":"16","key":"10.1016\/j.pharmthera.2024.108751_bib863","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2024.108751_bib869","doi-asserted-by":"crossref","first-page":"111344","DOI":"10.1016\/j.exger.2021.111344","article-title":"The pleiotropic beneficial intervention of olive oil intake on the Alzheimer\u2019s disease onset via fibrinolytic system","volume":"150","author":"Tzekaki","year":"2021","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in Huntington\u2019s disease: A few new twists on an old tale","volume":"348","author":"Valad\u00e3o","year":"2020","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2022.866434","article-title":"Vagus nerve stimulation as a potential therapy in early Alzheimer\u2019s disease: A review","volume":"16","author":"Vargas-Caballero","year":"2022","journal-title":"Frontiers in Human Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bib866","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13195-022-01097-2","article-title":"Genistein effect on cognition in prodromal Alzheimer\u2019s disease patients. The GENIAL clinical trial","volume":"14","author":"Vi\u00f1a","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bb0680","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","article-title":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-\u03b2 peptide metabolism","volume":"285","author":"Vingtdeux","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0685","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12974-020-01976-1","article-title":"Neuroprotective effects of verbascoside against Alzheimer\u2019s disease via the relief of endoplasmic reticulum stress in A\u03b2-exposed U251 cells and APP\/PS1 mice","volume":"17","author":"Wang","year":"2020","journal-title":"Journal of Neuroinflammation"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0690","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.7150\/ijbs.69714","article-title":"Forsythoside A mitigates Alzheimer\u2019s-like pathology by inhibiting ferroptosis-mediated neuroinflammation via Nrf2\/GPX4 axis activation","volume":"18","author":"Wang","year":"2022","journal-title":"International Journal of Biological Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108751_bb0695","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.3390\/ijms24065896","article-title":"Berberine rescues D-ribose-induced Alzheimer\u2019s pathology via promoting mitophagy","volume":"24","author":"Wang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"15","key":"10.1016\/j.pharmthera.2024.108751_bb0700","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1039\/C9NR01255A","article-title":"Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT\/GSK-3\u03b2 pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0705","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41398-020-00918-y","article-title":"Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer\u2019s disease-type pathology and cognitive deficits in APP\/PS1 mice","volume":"10","author":"Wang","year":"2020","journal-title":"Translational Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0710","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0715","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231193816","article-title":"Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China","volume":"16","author":"Wang","year":"2023","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0720","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainresbull.2019.08.006","article-title":"Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy","volume":"153","author":"Wang","year":"2019","journal-title":"Brain Research Bulletin"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108751_bb0725","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","article-title":"Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2018.03.008","article-title":"Fisetin exerts antioxidant and neuroprotective effects in multiple mutant hSOD1 models of amyotrophic lateral sclerosis by activating ERK","volume":"379","author":"Wang","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106874","article-title":"Tricin promoted ATG-7 dependent autophagic degradation of \u03b1-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson\u2019s disease","volume":"196","author":"Wang","year":"2023","journal-title":"Pharmacological Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108751_bb0740","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154281","article-title":"Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson\u2019s disease","volume":"104","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108751_bb0750","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1080\/15548627.2021.1872187","article-title":"Crocetin promotes clearance of amyloid-\u03b2 by inducing autophagy via the STK11\/LKB1-mediated AMPK pathway","volume":"17","author":"Wani","year":"2021","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.pharmthera.2024.108751_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111261","article-title":"Huntingtin coordinates dendritic spine morphology and function through cofilin-mediated control of the actin cytoskeleton","volume":"40","author":"Wennagel","year":"2022","journal-title":"Cell Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0760","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108751_bb0765","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/1028415X.2017.1297023","article-title":"An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Winter","year":"2017","journal-title":"Nutritional Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108751_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16195","article-title":"Curcumin protects against rotenone-induced Parkinson\u2019s disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108751_bb0775","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/cells11071093","article-title":"Modulating the ubiquitin-proteasome system: A therapeutic strategy for autoimmune diseases","volume":"11","author":"Yadav","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108751_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41538-021-00084-5","article-title":"Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway","volume":"5","author":"Yamamoto","year":"2021","journal-title":"npj Science of Food"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0785","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.apsb.2022.01.017","article-title":"Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates tau pathology: Implications for Alzheimer\u2019s disease therapy","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.659678","article-title":"Silybin alleviates experimental autoimmune encephalomyelitis by suppressing dendritic cell activation and Th17 cell differentiation","volume":"12","author":"Yang","year":"2021","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0795","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10787-017-0348-x","article-title":"Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson\u2019s disease dementia in rats","volume":"25","author":"Yang","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117448","article-title":"Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells","volume":"249","author":"Yang","year":"2020","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108751_bb0805","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308393","article-title":"Natural polyphenolic nanodots for Alzheimer\u2019s disease treatment","volume":"36","author":"Yang","year":"2024","journal-title":"Advanced Materials"},{"issue":"9","key":"10.1016\/j.pharmthera.2024.108751_bb0810","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","article-title":"Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum","volume":"42","author":"Yang","year":"2020","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0815","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fphar.2019.00863","article-title":"Scopoletin suppresses activation of dendritic cells and pathogenesis of experimental autoimmune encephalomyelitis by inhibiting NF-kappaB signaling","volume":"10","author":"Zhang","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bb0820","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1111\/cns.14309","article-title":"Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson\u2019s disease: A pilot randomized study","volume":"29","author":"Zhang","year":"2023","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108751_bb0825","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1039\/C8FO00964C","article-title":"Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T \u03b1-synuclein mouse model of Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Food & Function"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108751_bb0830","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.18632\/aging.103215","article-title":"Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104538","article-title":"Caffeic acid reduces A53T \u03b1-synuclein by activating JNK\/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"150","author":"Zhang","year":"2019","journal-title":"Pharmacological Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0840","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/10408398.2018.1546668","article-title":"A critical review on grape polyphenols for neuroprotection: Strategies to enhance bioefficacy","volume":"60","author":"Zhao","year":"2020","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1016\/j.pharmthera.2024.108751_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117043","article-title":"Amentoflavone suppresses amyloid \u03b21-42 neurotoxicity in Alzheimer\u2019s disease through the inhibition of pyroptosis","volume":"239","author":"Zhao","year":"2019","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108751_bb0850","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s11481-019-09866-x","article-title":"Neuroprotective effects of genistein in a SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"14","author":"Zhao","year":"2019","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108751_bb0855","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.apsb.2022.07.019","article-title":"Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharmaceutica Sinica B"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:46:12Z","timestamp":1733532372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725824001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":186,"alternative-id":["S0163725824001712"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108751","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential therapeutic strategy in combating neurodegenerative diseases: Focusing on natural products","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108751"}}